Overactive Bladder (OAB)

[gtranslate]
WhatsApp
Email
[brochureHTML]
More Information
Download Printable PDF
  1. Eapen RS, Radomski SB. Review of the epidemiology of overactive bladder. Res Rep Urol. 2016;8:71-76. doi:10.2147/RRU.S102441.

 

  1. Janse van Vuuren AC, van Rensburg JA, Hanekom S. Practitioner’s knowledge, attitudes, beliefs and practices towards urinary incontinence. S Afr J Physiother. 2023;79(1):1860. doi:10.4102/sajp.v79i1.1860.

 

  1. Yang CF, Huang CY, Wang SY, et al. Prevalence of and associated factors for overactive bladder subtypes in middle-aged women: A cross-sectional study. Medicina (Kaunas). 2022;58(3):383. doi:10.3390/medicina58030383.

 

  1. Overactive bladder. University Hospitals Sussex NHS Foundation Trust. December 20, 2022. Accessed August 5, 2024. https://www.uhsussex.nhs.uk/resources/overactive-bladder/.

 

  1. Sam P, Nassereddin A, LaGrange CA. Anatomy, abdomen and pelvis: Bladder detrusor muscle. In: StatPearls. StatPearls Publishing; 2024. Accessed August 5, 2024. http://www.ncbi.nlm.nih.gov/books/NBK482181/.

 

  1. Mobeen S, Apostol R. Ovarian cyst. In: StatPearls. StatPearls Publishing; 2024. Accessed August 5, 2024. http://www.ncbi.nlm.nih.gov/books/NBK560541/.

 

  1. Robinson D, Toozs-Hobson P, Cardozo L. The effect of hormones on the lower urinary tract. Menopause Int. 2013;19(4):155-162. doi:10.1177/1754045313511398.

 

  1. Van Brummen HJ, Bruinse HW, Van De Pol G, et al. Bothersome lower urinary tract symptoms 1 year after first delivery: Prevalence and the effect of childbirth. BJU International. 2006;98(1):89-95. doi:10.1111/j.1464-410X.2006.06211.x.

 

  1. Zhu J, Hu X, Dong X, et al. Associations between risk factors and overactive bladder: A meta-analysis. Female Pelvic Med Reconstr Surg. 2019;25(3):238-246. doi:10.1097/SPV.0000000000000531.

 

  1. Hagovska M, Švihra J, Buková A, et al. The relationship between overweight and overactive bladder symptoms. Obes Facts. 2020;13(3):297-306. doi:10.1159/000506486.

 

  1. Urinary incontinence – Diagnosis. nhs.uk. Last reviewed June 15, 2023. Accessed August 5, 2024. https://www.nhs.uk/conditions/urinary-incontinence/diagnosis/.

 

  1. Queremel Milani DA, Jialal I. Urinalysis. In: StatPearls. StatPearls Publishing; 2024. Accessed August 5, 2024. http://www.ncbi.nlm.nih.gov/books/NBK557685/.

 

  1. Moslemi MK, Mahfoozi B. Urologist-operated ultrasound and its use in urological outpatient clinics. Patient Prefer Adherence. 2011;5:85-88. doi:10.2147/PPA.S17132.

 

  1. Urinary tract imaging. National Institute of Diabetes and Digestive and Kidney Diseases. Accessed August 5, 2024. https://www.niddk.nih.gov/health-information/diagnostic-tests/urinary-tract-imaging.

 

  1. Engelsgjerd JS, Deibert CM. Cystoscopy. In: StatPearls. StatPearls Publishing; 2024. Accessed August 5, 2024. http://www.ncbi.nlm.nih.gov/books/NBK493180/.

 

  1. Urodynamic testing. National Institute of Diabetes and Digestive and Kidney Diseases. Accessed August 5, 2024. https://www.niddk.nih.gov/health-information/diagnostic-tests/urodynamic-testing.

 

  1. Mehr AA, Kreder KJ, Lutgendorf SK, et al. Daily symptom associations for urinary urgency and anxiety, depression and stress in women with overactive bladder. Int Urogynecol J. 2022;33(4):841-850. doi:10.1007/s00192-021-05033-0.

 

  1. Ghossein N, Kang M, Lakhkar AD. Anticholinergic medications. In: StatPearls. StatPearls Publishing; 2024. Accessed August 5, 2024. http://www.ncbi.nlm.nih.gov/books/NBK555893/.

 

  1. Baruch Y, Torella M, De Bastiani S, et al. Pre- versus post-menopausal onset of overactive bladder and the response to vaginal estrogen therapy: A prospective study. Medicina (Kaunas). 2023;59(2):245. doi:10.3390/medicina59020245.

 

  1. Fitz F, Sartori M, Girão MJ, et al. Pelvic floor muscle training for overactive bladder symptoms – A prospective study. Rev Assoc Med Bras. 2017;63:1032-1038. doi:10.1590/1806-9282.63.12.1032.

 

  1. Hsieh PF, Chiu HC, Chen KC, et al. Botulinum toxin A for the treatment of overactive bladder. Toxins (Basel). 2016;8(3):59. doi:10.3390/toxins8030059.

 

  1. Bhide AA, Tailor V, Fernando R, et al. Posterior tibial nerve stimulation for overactive bladder—Techniques and efficacy. Int Urogynecol J. 2020;31(5):865-870. doi:10.1007/s00192-019-04186-3.

 

  1. Feloney MP, Stauss K, Leslie SW. Sacral neuromodulation. In: StatPearls. StatPearls Publishing; 2024. Accessed August 5, 2024. http://www.ncbi.nlm.nih.gov/books/NBK567751/.

 

  1. Veeratterapillay R, Thorpe AC, Harding C. Augmentation cystoplasty: Contemporary indications, techniques and complications. Indian J Urol. 2013;29(4):322-327. doi:10.4103/0970-1591.120114.

 

  1. Jin Z, Zhang Q, Yu Y, et al. Progress in overactive bladder: Novel avenues from psychology to clinical opinions. PeerJ. 2023;11:e16112. doi:10.7717/peerj.16112.

Related Brochures

[sidebarBrochures]